Последние добавленные видео:
Speaker:-Alexander-Spira
-
3 years ago
232 3 years ago 1:14DESTINY-Lung01: a practice-changing trial for NSCLC
-
2 years ago
47933348 2 years ago 3:44Britney Spears - Criminal (Lyrics)
-
1 month ago
123 1 month ago 1:12Expanding KRAS-targeted therapies with RMC compounds and pan-RAS inhibitors
-
3 years ago
240 3 years ago 1:22KRYSTAL-1: activity and safety of adagrasib in patients with advanced/metastatic KRASG12Cm NSCLC
-
15 years ago
498430007 15 years ago 4:13Britney Spears - Oops!...I Did It Again (Official HD Video)
-
9 months ago
112 9 months ago 1:05METalmark: amivantamab and capmatinib in advanced NSCLC
-
1 month ago
22 1 month ago 1:13What does the future hold for T-cell engagers in oncology?
-
9 months ago
164 9 months ago 1:05Management of adverse events from datopotamab deruxtecan in NSCLC
-
3 years ago
568 3 years ago 1:08How will adagrasib fit into the treatment landscape of KRASG12-mutant NSCLC?
-
6 months ago
123 6 months ago 3:22ASP Ioudspeakers
-
10 months ago
143 10 months ago 1:08Valemetostat and datopotamab deruxtecan in advanced NSCLC
-
3 years ago
328 3 years ago 1:46The evolving treatment landscape for NSCLC with EGFR exon 20 insertion mutations
-
9 months ago
159 9 months ago 1:28MARIPOSA: follow-up of lazertinib with amivantamab or osimertinib in EGFR-m NSCLC
-
5 months ago
454 5 months ago 1:13RMC-9805: Phase I results in patients with KRAS G12D pancreatic ductal adenocarcinoma
-
4 years ago
1433 4 years ago 1:36Efficacy of datopotamab deruxtecan, a TROP2 ADC, in aNSCLC
-
4 years ago
241 4 years ago 1:30CANOPY-A: canakinumab for resected NSCLC